ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Search term may appear only in full report available to members. Join now for full access.

Product Review

Joint Health Supplements for Pets Review (Glucosamine, Chondroitin, MSM & Boswellia)

See Which Pet Supplements for Joint Health Passed Our Tests and Which Didn't!

Joint Health Supplements for Pets

Product Review

Joint Health Supplements Review (Glucosamine, Chondroitin, MSM, Boswellia, Collagen and Turmeric)

One-Third of Joint Health Supplements Failed to Pass Our Tests. See Which Passed or Failed, and our Top Picks.

Review of Supplements for Joint Pain

Product Review

Probiotic Supplements Review (Including Pet Probiotics)

Probiotics: See What They Really Contain and Our Top Picks

Product Review

SAMe (S-adenosyl-methionine) Supplements Review

Choose the Best SAMe Supplement and Save Money

SAMe 2024 v2

News Release

March 06, 2007

ConsumerLab.com produces series of free online seminars about dietary supplements — First seminar on "joint health" now available

WHITE PLAINS, NEW YORK — MARCH 6, 2007 — ConsumerLab.com announced today that it is producing and webcasting a series of free, online audio seminars, or "webinars," that explain the use of popular types of dietary supplements.

Recalls & Warnings

July 15, 2004

Company Stopped by FTC from Claiming to Prevent or Reverse Memory Loss without Evidence

On July 13, 2004, the Federal Trade Commission(FTC) announced that a dietary supplement manufacturer has settled FTC charges that it violated federal law by making unsubstantiated claims that its product, “Senior Moment,” could prevent memory loss and restore memory function in adults.

Recalls & Warnings

March 12, 2016

FDA Finds Problems at 58% of Supplement Manufacturing Sites in U.S. and Abroad

ConsumerLab.com has obtained results of the FDA's inspections in Fiscal Year 2015 (ending September 30) of 483 dietary supplement manufacturing facilities, showing that most -- 58.2% -- received letters indicating noncompliance with current Good Manufacturing Practices (cGMPs).